Copertina

Evaluating a Pragmatic Strength Alternative for Frailty Measurement and Assessing Its Predictive Capacity Against Established Frailty Instruments in Rheumatoid Arthritis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kylie E. Riggles, Hannah F. Brubeck, Adrienne D. Tanus, Courtney N. Loecker, Punyasha Roul, Bryant R. England, Elizabeth R. Wahl, James S. Andrews, Namrata Singh, Joshua F. Baker, Patricia P. Katz, Dolores M. Shoback, Jose M. Garcia, Ariela R. Orkaby, Katherine D. Wysham
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Arthritis Care & Research
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?
di: Hannah F. Brubeck, et al.
Pubblicazione: (2025)

Exploring Factors Associated With Cognitive Impairment in Rheumatoid Arthritis
di: Raquelle Dawood, et al.
Pubblicazione: (2026)

Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis
di: Joshua F. Baker, et al.
Pubblicazione: (2025)

The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
di: Rebecca T. Brooks, et al.
Pubblicazione: (2024)

Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas
di: Anisha Naik, et al.
Pubblicazione: (2024)

Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis
di: Beth I. Wallace, et al.
Pubblicazione: (2025)

Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
di: Vanessa L. Kronzer, et al.
Pubblicazione: (2025)

Two Birds, One Stone: Lung Cancer Screening in Patients With Rheumatoid Arthritis Identifies Malignancy and Rheumatoid Arthritis–Associated Lung Disease
di: Amir A. Razmjou, et al.
Pubblicazione: (2026)

Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis
di: Tate M. Johnson, et al.
Pubblicazione: (2026)

Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease
di: Austin M. Wheeler, et al.
Pubblicazione: (2025)

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes
di: Bryant R. England, et al.
Pubblicazione: (2025)

Frailty: A New Vital Sign in Rheumatology Care?
di: Alexandra Legge, et al.
Pubblicazione: (2026)

Antibodies to Malondialdehyde‐Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis–Associated Interstitial Lung Disease in US Veterans
di: Nozima Aripova, et al.
Pubblicazione: (2024)

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
di: Brent A. Luedders, et al.
Pubblicazione: (2026)

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration
di: Lindsay N. Helget, et al.
Pubblicazione: (2025)

Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data
di: Stephanie Song, et al.
Pubblicazione: (2024)

Behavioral Incentives for Exercise and Intra‐Articular Glucocorticoids for Knee Osteoarthritis: Results From a Factorially Designed Pragmatic Randomized Clinical Trial
di: Joshua F. Baker, et al.
Pubblicazione: (2026)

Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk
di: Kelsey Coziahr, et al.
Pubblicazione: (2026)

Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
di: Joshua F. Baker, et al.
Pubblicazione: (2024)

Metabolic Consequences of Rheumatoid Arthritis
di: Stevie Barry, et al.
Pubblicazione: (2025)

Reply
di: Bryant R. England, et al.
Pubblicazione: (2024)

Another Notch in the Belt of Rheumatoid Arthritis
di: Stephanie R. Zack, et al.
Pubblicazione: (2024)

Reply
di: Vanessa L. Kronzer, et al.
Pubblicazione: (2025)

Air Pollution's Hidden Toll: Risks for Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Lung Disease
di: Sofia Ajeganova, et al.
Pubblicazione: (2025)

Financial Distress and Its Determinants in Rheumatoid Arthritis
di: Amber Brown Keebler, et al.
Pubblicazione: (2025)

Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial
di: Marianna Jasenecova, et al.
Pubblicazione: (2026)

Measuring Frailty in Systemic Lupus Erythematosus
di: Patricia Katz, et al.
Pubblicazione: (2025)

A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis
di: Kevin D. Deane, et al.
Pubblicazione: (2026)

EULAR /American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia
di: Hanna W. van Steenbergen, et al.
Pubblicazione: (2025)

Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems
di: David Cheng, et al.
Pubblicazione: (2026)

Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis
di: Veerle F. A. M. Derksen, et al.
Pubblicazione: (2024)

Two Broad Categories Overlapping With Rheumatoid Arthritis Observed in Synovial Biopsies from Patients With Juvenile Idiopathic Arthritis
di: Clément Triaille, et al.
Pubblicazione: (2024)

Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real‐World Early Rheumatoid Arthritis Cohort
di: Charis F. Meng, et al.
Pubblicazione: (2024)

Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib
di: Runa Kuley, et al.
Pubblicazione: (2024)

Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses
di: Sho Sendo, et al.
Pubblicazione: (2024)

Late‐Onset Rheumatoid Arthritis and Air Pollution in the Multiethnic Cohort
di: Anna H. Wu, et al.
Pubblicazione: (2026)

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts
di: Kevin J. Sheridan, et al.
Pubblicazione: (2026)

Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis–Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification
di: Pierre‐Antoine Juge, et al.
Pubblicazione: (2024)

Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis
di: Chuan Fu Yap, et al.
Pubblicazione: (2025)

Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis
di: Kun Zhao, et al.
Pubblicazione: (2026)